Skip to main content
OpenTrials

Clinical trial condition

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification

Explore clinical trials studying Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification trial results

Active, Not Recruiting

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

NCT02864992

Conditions
Adenocarcinoma, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Bronchial Neoplasms, +13 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • St. Joseph Hospital Orange, California, United States
  • Torrance Health Association Redondo Beach, California, United States
View all 176 locations
View Trial Details

Related conditions